Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
TherapeuticsMD, Inc. (TXMD) had Stock-Based Compensation of $0.00M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$0.72M |
|
$0.10M |
|
-- |
|
$0.72M |
|
$1.45M |
|
$-0.72M |
|
$0.83M |
|
$0.10M |
|
$0.10M |
|
$0.10M |
|
$0.10M |
|
$0.10M |
|
$0.10M |
|
$-0.72M |
|
$-0.40M |
|
11.57M |
|
11.64M |
|
$0.01 |
|
$0.01 |
|
| Balance Sheet Financials | |
$15.26M |
|
-- |
|
$22.32M |
|
$37.58M |
|
$4.91M |
|
-- |
|
$5.70M |
|
$10.61M |
|
$26.97M |
|
$23.31M |
|
$26.97M |
|
11.57M |
|
| Cash Flow Statement Financials | |
$0.94M |
|
-- |
|
-- |
|
$7.48M |
|
$8.42M |
|
$0.94M |
|
|
Stock-Based Compensation |
$0.00M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.11 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-99.86% |
|
-99.86% |
|
-- |
|
14.23% |
|
13.12% |
|
$0.94M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
0.23 |
|
399.16 |
|
0.38% |
|
0.44% |
|
0.27% |
|
0.38% |
|
$2.33 |
|
$0.08 |
|
$0.08 |
|